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in Renal Transplantation
To the Editor:
We appreciate the comments of Drs. Opelz and Döhler re-
garding our submission to the American Journal of Trans-
plantation (1). The authors correctly point out that our
series, which encompassed 634 deceased donor and 950
living donor transplants, was not sufficiently powered to
detect a difference in UW versus HTK performance in
organs cold-preserved for more than 24 h. Our study
did show, to a statistically significant degree, apparent
equipoise in patient and graft survival between the whole
of the UW and HTK groups. Separate multivariate analy-
ses of outcomes validated the data set by showing con-
tributions of donor and recipient factors consistent with
previous reports from the literature (2,3). Finally, our study
assessed correlation between storage solution type and
delayed graft function, and HTK use was actually seen by
Cox multivariable analysis to be associated with decreased
risk of delayed graft function.
The results of the Collaborative Transplant Study, to which
Drs. Opelz and Döhler allude, did show a detrimental effect
of preservation with HTK over UW in prolonged ischemia
times (4). This excellent work reports on 16 years of reg-
istry data. As in our own experience, the authors noted
shifts in preservative fluid type and the proportion of or-
gans stored for longer than 24 h over the course of the
collection period. While this registry data can be used to
calculate a hazard ratio to control for the era effect in our
own study, the applicability of such a factor derived from an
aggregate of heterogeneous data to a single center’s prac-
tices is not certain. Nonetheless, Drs. Opelz and Döhler
correctly comment on an important weakness of our re-
port, the potential confounding effects of secular trends
on our results. We clearly discussed this in the original
manuscript.
In summary, final proof of the superiority of HTK over UW
or vice versa as a renal preservative remains elusive. In the
absence of any new randomized trial of sufficient power
and granularity to assess all factors and outcomes of renal
transplantation using the two solutions, large reports such
as the Collaborative Transplant Study and smaller series
such as our own provide complementary information on
renal preservation. Our experience shows little, if any, dif-
ference between the fluids within the scope of our usual
ischemia times, and as HTK has cost and ease of use bene-
fits (5), it remains our standard choice for cold preservation
of renal allografts.
R. Lynch and M. Englesbe
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